Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

Simone N. Koole, Ruby M. van Stein, Karolina Sikorska, Desmond P.J. Barton, Lewis Perrin, Donal J. Brennan, Oliver Zivanovic, Berit Jul Mosgaard, Anna Fagotti, Pierre‐Emmanuel Colombo, Gabe S. Sonke, Willemien J. van Driel, N. Bakrin, S. Banerjee, S. Barry, D.P. Barton, D. Brennan, P.E. Colombo, M. Deraco, W.J. van Driel, A. Fagotti, R. Farrell, R. Grisham, B.J. Mosgaard, I. McNeish, L. Perrin, G.S. Sonke, O. Zivanovic, H.J.G. Arts, I. Boere, G.J. Creemers, W.J. van Driel, K.N. Gaarenstroom, M. van Gent, M. van Ham, B. Hellebrekers, R. Hermans, I. de Hingh, S.N. Koole, J.R. Kroep, C.D. de Kroon, R. Lalisang, S. Lambrechts, P. Ottevanger, N. Reesink, V. Retel, A.K.L. Reyners, E.M. Roes, H.W.R. Schreuder, G.S. Sonke, R.M. van Stein, A. Thijs, A. Westermann, P.O. Witteveen, A. Wymenga, R. Yigit